Paul D. Burgess Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

CERE Quotes by TradingView

Paul D. Burgess is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 45,727 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Paul D. Burgess Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
SELL
Sale (or disposition) back to the issuer
-
45,727 Reduced 100.0%
0 Common Stock
Dec 19 2023
BUY
Exercise of conversion of derivative security
-
23,847 Added 34.28%
45,727 Common Stock
Aug 04 2023
BUY
Open market or private purchase
$501,708 $22.93 p/Share
21,880 Added 50.0%
21,880 Common Stock

Also insider at

TBIO
Translate Bio, Inc. Healthcare
Chief Operating Officer, CLO
PDB

Paul D. Burgess

Lexington, MA

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CERE